Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patients

Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke

(2010) Helena Manso et al.   BMC Medical Genetics

Matrix metalloproteinase 9 gene haplotypes affect left ventricular hypertrophy in hypertensive patients

(2010) Riccardo Lacchini et al.   CLINICA CHIMICA ACTA

MMP-2 and TIMP-2 gene polymorphisms and susceptibility to atrial fibrillation in Chinese Han patients with hypertensive heart disease

(2010) Xiaobo Gai et al.   CLINICA CHIMICA ACTA

Matrix Metalloproteinase Inhibition Improves Cardiac Dysfunction and Remodeling in 2-Kidney, 1-Clip Hypertension

(2010) Élen Rizzi et al.   JOURNAL OF CARDIAC FAILURE

Matrix metalloproteinase (MMP-9 and MMP-2) gene polymorphisms influence allograft survival in renal transplant recipients

(2010) R. Singh et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

MMP-2/TIMP-2/TIMP-4 versus MMP-9/TIMP-3 in transition from compensatory hypertrophy and angiogenesis to decompensatory heart failure*

(2010) Srikanth Givvimani et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix

(2009) A. D. Kandasamy et al.   CARDIOVASCULAR RESEARCH

Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension

(2009) Michele M. Castro et al.   FREE RADICAL BIOLOGY AND MEDICINE

Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling

(2009) Michele M. Castro et al.   MATRIX BIOLOGY

Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy

(2008) Vanessa Roldán et al.   AMERICAN HEART JOURNAL

MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not

(2008) A M J Langers et al.   BRITISH JOURNAL OF CANCER

Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats

(2008) Marcio L.L. Martinez et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Progress in matrix metalloproteinase research

(2008) G MURPHY et al.   MOLECULAR ASPECTS OF MEDICINE

Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats

(2007) Michele M. Castro et al.   ATHEROSCLEROSIS